AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Continente #
AS - Asia 5.313
NA - Nord America 1.043
EU - Europa 514
SA - Sud America 34
AF - Africa 8
OC - Oceania 8
Totale 6.920
Nazione #
SG - Singapore 4.612
US - Stati Uniti d'America 999
CN - Cina 404
HK - Hong Kong 220
GB - Regno Unito 142
IT - Italia 134
DE - Germania 73
FI - Finlandia 46
NL - Olanda 38
BR - Brasile 28
CA - Canada 28
TR - Turchia 21
IN - India 19
FR - Francia 14
PL - Polonia 14
MX - Messico 13
VN - Vietnam 12
CZ - Repubblica Ceca 10
JP - Giappone 10
LT - Lituania 10
AU - Australia 8
ES - Italia 7
AT - Austria 6
UA - Ucraina 6
ZA - Sudafrica 4
BD - Bangladesh 3
ID - Indonesia 3
SE - Svezia 3
HU - Ungheria 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TN - Tunisia 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
YT - Mayotte 1
Totale 6.920
Città #
Singapore 221
Hong Kong 216
Dallas 214
Hefei 206
Ashburn 184
London 122
Boardman 115
Shanghai 71
Beijing 63
Council Bluffs 59
Munich 56
West Jordan 40
Los Angeles 37
Rome 35
Amsterdam 30
Turku 24
San Francisco 23
Washington 23
Helsinki 22
Santa Clara 22
Sona 20
Seattle 19
Bari 15
Ankara 14
Warsaw 14
Toronto 13
São Paulo 12
Pune 11
Brno 10
Brooklyn 10
Tokyo 10
Atlanta 9
Boston 8
Mexico City 8
New York 8
Changsha 7
Charlotte 7
Ho Chi Minh City 7
Chicago 5
Milan 5
Montreal 5
Chengdu 4
Chennai 4
Duino-Aurisina 4
Haikou 4
Naples 4
Noicattaro 4
Paris 4
State College 4
Denver 3
Johannesburg 3
Manchester 3
Philadelphia 3
Phoenix 3
Redmond 3
San Jose 3
Secaucus 3
Sydney 3
The Dalles 3
Vienna 3
Vilnius 3
Brest 2
Canberra 2
Central 2
Charleston 2
Cuernavaca 2
Guiyang 2
Haiphong 2
Handan 2
Herne Bay 2
Honolulu 2
Linyi 2
Melbourne 2
Messina 2
Orem 2
Perugia 2
Reus 2
Rockville 2
Stockholm 2
Tianjin 2
Topeka 2
Ajman 1
Almere Stad 1
Amman 1
Annapolis 1
Atibaia 1
Augusta 1
Bekasi 1
Belgrade 1
Belém 1
Benito Juarez 1
Bologna 1
Borås 1
Bourne 1
Brasília 1
Budapest 1
Buffalo 1
Caldas Novas 1
Calgary 1
Carney 1
Totale 2.127
Nome #
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 200
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 200
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 198
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 198
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 196
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 196
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 195
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 192
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 185
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 184
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 182
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 177
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 176
Leptin in immuno-rheumatological diseases 170
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 106
GH-resistance in different stages of chronic liver disease 104
Diabetes in chronic liver disease: from old concepts to new evidence 101
Enhanced portal flow velocity and volume following Iloprost treatment 100
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 99
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 98
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 95
Radiofrequency ablation of hepatic tissue: a new experimental animal model 95
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 95
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 93
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 91
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 90
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 89
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 86
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 86
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 86
Cannabinoids in Autoimmune and Rheumatic Diseases 85
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 85
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 84
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 83
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 83
Leptin in autoimmune mechanisms of systemic rheumatic diseases 82
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 80
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 80
ANA testing in ‘real life’ 79
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 76
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 75
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 70
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 69
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 66
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 64
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 61
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 61
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 54
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 52
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 48
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 41
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 38
TNF-alpha and growth hormone resistance in patients with chronic liver disease 37
Pain and Frailty in Hospitalized Older Adults 36
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 35
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 34
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 33
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 33
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 32
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 32
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 31
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 30
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 29
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 29
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 29
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 28
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 27
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 27
Matters of the heart: The case of TNF-alpha targeting drugs 27
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 27
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 26
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 26
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 26
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 25
Surgical complications after resection of adrenal carcinoma 25
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 25
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 25
Utility of ultrasound in the diagnosis of chronic worsened gout 24
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 24
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 24
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 24
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 23
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 23
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 23
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 23
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 23
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 23
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 22
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 22
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 22
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 22
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 21
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 21
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 21
Serum level of endostatin and digital ulcers in systemic sclerosis patients 21
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 21
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 21
Phase angle could be a marker of microvascular damage in systemic sclerosis 21
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 20
In systemic sclerosis, microvascular and hands digital arteries damage correlates with serum levels of endostatin 18
Totale 6.920
Categoria #
all - tutte 41.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/2026760 324 193 243 0 0 0 0 0 0 0 0 0
Totale 6.986